Skip to content

  • INVESTORS
    • PRESENTATION
MY ACCOUNT
SCHEDULE A TEST
CALL 800-522-7424
Psychemedics
  • ABOUT
  • HAIR TESTING
    • The Science Behind Hair Drug Testing
    • Words of Warning
    • 5-Panel Drug Test
      • Amphetamines
      • Cocaine
      • Marijuana
      • Opiates
      • PCP Hair Drug Test
    • Fentanyl Hair Drug Testing
    • Adderall Testing
    • Benzodiazepines Testing
    • Synthetic Cannabinoids
    • Hair Alcohol Testing (EtG)
    • At Home Drug Testing Kit – PDT 90
    • Hair Test FAQs
  • INDUSTRIES
    • Education/School Drug Testing
    • Transportation
    • Services
    • Manufacturing
    • Oil and Gas
    • Law Enforcement
  • WHY PSYCHEMEDICS
  • RESOURCES
    • Blogs
    • White Papers
    • Press Releases
    • For Our Clients
    • Case Studies
    • Representative Cases
  • COLLECTORS
  • CONTACT

Corporate Newsletter – Oct 2017

January 16, 2020September 28, 2017 by Psychemedics

Download the PDF file Corporate Newsletter - Oct 2017.
Categories Corporate, Newsletters
Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
Psychemedics School Newsletter – April 24 2017

Recent Posts

  • Psychemedics Corporation Announces Reverse and Forward Stock Split
  • Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders
  • The Future of Drug Testing in Education: Key Insights from the 2024 Psychemedics Education Insights Report
  • Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
  • The Rise of Ketamine: Understanding the Growing Trend and the Value of Hair Testing

Categories

  • Blog Posts
  • Corporate
  • Drug News
  • Fentanyl
  • Healthcare
  • News
  • Newsletters
  • Press Releases
  • Schools
  • Uncategorized
  • Webinars
CORPORATE HEADQUARTERS
5220 Spring Valley Road, Ste 230
Dallas, TX 75254
United States
(800) 522-7424

PSYCHEMEDICS

Home

Hair Testing

Industries

Collectors

Call 800-522-7424

© Copyright 2024 – Psychemedics Corporation
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to the application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the Investor Relations section in order to receive the most current information made available by Psychemedics Corporation.

© 2025 Psychemedics • Built with GeneratePress